Britt Skogseid

Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma

Backman, Samuel; Axling, Fredrik; Zhang, Liang; Botling, Johan et al.

Part of Endocrine pathology, 2026

• DOI for Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma
• Download full text (pdf) of Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma

Lipid synthesis seems to drive proliferation in Men1 mouse adrenals and human adrenocortical cell lines

Edholm, Adam; Li, Su-Chen; Chu, Xia; Wargelius, Hanna-Linn et al.

Part of Endocrine-Related Cancer, 2026

• DOI for Lipid synthesis seems to drive proliferation in Men1 mouse adrenals and human adrenocortical cell lines

The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study

Mollazadegan, Kazhan; Botling, Johan; Skogseid, Britt; Eriksson, Barbro et al.

Part of Journal of neuroendocrinology, 2025

• DOI for The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study
• Download full text (pdf) of The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study

The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation

Backman, Samuel; Botling, Johan; Nord, Helena; Ghosal, Suman et al.

Part of Journal of Pathology, p. 357-370, 2024

• DOI for The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation
• Download full text (pdf) of The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation

Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors

Falkman, Lovisa; Sundin, Anders; Skogseid, Britt; Botling, Johan et al.

Part of Upsala Journal of Medical Sciences, 2024

• DOI for Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors
• Download full text (pdf) of Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors

Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma

Backman, Samuel; Axling, Fredrik; Zhang, Liang; Botling, Johan et al.

Part of Endocrine pathology, 2026

• DOI for Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma
• Download full text (pdf) of Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma

Lipid synthesis seems to drive proliferation in Men1 mouse adrenals and human adrenocortical cell lines

Edholm, Adam; Li, Su-Chen; Chu, Xia; Wargelius, Hanna-Linn et al.

Part of Endocrine-Related Cancer, 2026

• DOI for Lipid synthesis seems to drive proliferation in Men1 mouse adrenals and human adrenocortical cell lines

The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study

Mollazadegan, Kazhan; Botling, Johan; Skogseid, Britt; Eriksson, Barbro et al.

Part of Journal of neuroendocrinology, 2025

• DOI for The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study
• Download full text (pdf) of The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study

The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation

Backman, Samuel; Botling, Johan; Nord, Helena; Ghosal, Suman et al.

Part of Journal of Pathology, p. 357-370, 2024

• DOI for The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation
• Download full text (pdf) of The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation

Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors

Falkman, Lovisa; Sundin, Anders; Skogseid, Britt; Botling, Johan et al.

Part of Upsala Journal of Medical Sciences, 2024

• DOI for Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors
• Download full text (pdf) of Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors

Response to Letter to the Editor regarding 'Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma'

Zhang, Liang; Åkerström, Tobias; Mollazadegan, Kazhan; Beuschlein, Felix et al.

Part of Endocrine-Related Cancer, 2024

• DOI for Response to Letter to the Editor regarding 'Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma'

Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma

Zhang, Liang; Åkerström, Tobias; Mollazadegan, Kazhan; Beuschlein, Felix et al.

Part of Endocrine-Related Cancer, 2023

• DOI for Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma
• Download full text (pdf) of Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma

Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

Mollazadegan, Kazhan; Skogseid, Britt; Botling, Johan; Åkerström, Tobias et al.

Part of Endocrine Connections, 2022

• DOI for Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors
• Download full text (pdf) of Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

¹⁸F-Radiolabeling and Preliminary Evaluation of a HSP₉₀ ligand

Nordeman, Patrik; Jayendra, Z. P.; Briard, E.; Li, Su-Chen et al.

Part of European Journal of Pharmaceutical Sciences, 2021

• DOI for ¹⁸F-Radiolabeling and Preliminary Evaluation of a HSP₉₀ ligand

MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines

Li, Su-Chen; Monazzam, Azita; Razmara, Masoud; Chu, Xia et al.

Part of Scientific Reports, 2021

• DOI for MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines
• Download full text (pdf) of MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines

Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line

Monazzam, Azita; Li, Su-Chen; Wargelius, Hanna-Linn; Razmara, Masoud et al.

Part of Scientific Reports, 2020

• DOI for Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line
• Download full text (pdf) of Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line

High-grade progression confers poor survival in pancreatic neuroendocrine tumors

Botling, Johan; Lamarca, Angela; Bajic, Duska; Norlén, Olov et al.

Part of Neuroendocrinology, p. 891-898, 2020

• DOI for High-grade progression confers poor survival in pancreatic neuroendocrine tumors

Whole genome sequencing of apparently mutation-negative MEN1 patients

Backman, Samuel; Bajic, Duska; Crona, Joakim; Hellman, Per et al.

Part of European Journal of Endocrinology, p. 35-45, 2020

• DOI for Whole genome sequencing of apparently mutation-negative MEN1 patients

Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration

Razmara, Masoud; Monazzam, Azita; Skogseid, Britt

Part of Cell Communication and Signaling, 2018

• DOI for Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration
• Download full text (pdf) of Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration

Increased Expression of GLP-1R in Proliferating Islets of Men1 Mice is Detectable by [Ga-68]Ga-DO3A-VS-Cys(40)- Exendin-4/PET

Monazzam, Azita; Lau, Joey; Velikyan, Irina; Li, Su-Chen et al.

Part of Scientific Reports, 2018

• DOI for Increased Expression of GLP-1R in Proliferating Islets of Men1 Mice is Detectable by [Ga-68]Ga-DO3A-VS-Cys(40)- Exendin-4/PET
• Download full text (pdf) of Increased Expression of GLP-1R in Proliferating Islets of Men1 Mice is Detectable by [Ga-68]Ga-DO3A-VS-Cys(40)- Exendin-4/PET

RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective

Crona, Joakim; Backman, Samuel; Welin, Staffan; Taieb, David et al.

Part of Cancers, 2018

• DOI for RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective
• Download full text (pdf) of RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective

Neuroendocrine tumors with syndromic vasoactive intestinal polypeptide hypersecretion: a retrospective study

Antonodimitrakis, Pantelis Clewemar; Olofsson, Helena; Grimelius, Lars; Sundin, Anders et al.

Part of International Journal of Endocrine Oncology, p. 9-22, 2017

• DOI for Neuroendocrine tumors with syndromic vasoactive intestinal polypeptide hypersecretion: a retrospective study

Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing

Backman, Samuel; Norlén, Olov; Eriksson, Barbro; Skogseid, Britt et al.

Part of Anticancer Research, p. 705-712, 2017

• DOI for Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing

An Integrative Genomic Analysis of Formalin Fixed Paraffin-Embedded Archived Serous Ovarian Carcinoma Comparing Long-term and Short-term Survivors

Stålberg, Karin; Crona, Joakim; Razmara, Masoud; Taslica, Diana et al.

Part of International Journal of Gynecological Cancer, p. 1027-1032, 2016

• DOI for An Integrative Genomic Analysis of Formalin Fixed Paraffin-Embedded Archived Serous Ovarian Carcinoma Comparing Long-term and Short-term Survivors

miR-196a Is Specifically Regulated in FDG-PET Positive and Negative Small Intestinal Neuroendocrine Tumor Patients at Late Stage of Disease

Giandomenico, V; Li, Su-Chen; Lind, Thomas; Boccherini, M. et al.

Part of Neuroendocrinology, p. 115-115, 2016

Progranulin Stimulates Proliferation of Mouse Pancreatic Islet Cells and Is Overexpressed in the Endocrine Pancreatic Tissue of an MEN1 Mouse Model

Barbu, Andreea; Lejonklou, Margareta H; Skogseid, Britt

Part of Pancreas, p. 533-540, 2016

• DOI for Progranulin Stimulates Proliferation of Mouse Pancreatic Islet Cells and Is Overexpressed in the Endocrine Pancreatic Tissue of an MEN1 Mouse Model

Streptozocin and 5-FU for the treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity

Antonodimitrakis, Pantelis; Sundin, Anders; Wassberg, Cecilia; Granberg, Dan et al.

Part of Neuroendocrinology, p. 345-353, 2016

• DOI for Streptozocin and 5-FU for the treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity

Streptozocin and 5-fluorouracil treatment of pancreatic neuroendocrine tumors: efficacy, toxicity and prognostic factors

Eriksson, Barbro; Sundin, Anders; Wassberg, Cecilia; Skogseid, Britt et al.

Part of Wiener Klinische Wochenschrift, 2014

Multiple Microvascular Alterations in Pancreatic Islets and Neuroendocrine Tumors of a Men1 Mouse Model

Chu, Xia; Gao, Xiang; Jansson, Leif; Quach, My et al.

Part of American Journal of Pathology, p. 2355-2367, 2013

• DOI for Multiple Microvascular Alterations in Pancreatic Islets and Neuroendocrine Tumors of a Men1 Mouse Model

Comparison of Two Mitotane Starting dose Regimens in Patients with Advanced Adrenocortical Carcinoma

Kerkhofs, Tm; Baudin, E; Terzolo, M; Allolio, B et al.

Part of Journal of Clinical Endocrinology and Metabolism, p. 2281, 2013

• DOI for Comparison of Two Mitotane Starting dose Regimens in Patients with Advanced Adrenocortical Carcinoma

Prognostic Relevance of Survivin in Pancreatic Endocrine Tumors

Ekeblad, Sara; Halin Lejonklou, Margareta; Stålberg, Peter; Skogseid, Britt

Part of World Journal of Surgery, p. 1411-1418, 2012

• DOI for Prognostic Relevance of Survivin in Pancreatic Endocrine Tumors

Hög tid att söka till nya MD/PhD-programmet vid Uppsala universitet: Tidig bro mellan preklinisk forskning och klinik

Staaf, Johan; Åkerström, Tobias; Ljungström, Viktor; Larsson, Sune et al.

Part of Läkartidningen, p. 898-898, 2012

Combination chemotherapy in advanced adrenocortical carcinoma

Fassnacht, Martin; Terzolo, Massimo; Allolio, Bruno; Baudin, Eric et al.

Part of New England Journal of Medicine, p. 2189-2197, 2012

• DOI for Combination chemotherapy in advanced adrenocortical carcinoma

Accelerated Proliferation and Differential Global Gene Expression in Pancreatic Islets of Five-Week-Old Heterozygous Men1 Mice: Men1 Is a Haploinsufficient Suppressor

Lejonklou, Margareta H; Barbu, Andreea; Stålberg, Peter; Skogseid, Britt

Part of Endocrinology, p. 2588-2598, 2012

• DOI for Accelerated Proliferation and Differential Global Gene Expression in Pancreatic Islets of Five-Week-Old Heterozygous Men1 Mice: Men1 Is a Haploinsufficient Suppressor

PET-Guided Surgery: High Correlation between Positron Emission Tomography with ¹¹C-5-Hydroxytryptophane (5-HTP) and Surgical Findings in Abdominal Neuroendocrine Tumours

Örlefors, Håkan; Sundin, Anders; Eriksson, Barbro; Skogseid, Britt et al.

Part of Cancers, p. 100-112, 2012

• DOI for PET-Guided Surgery: High Correlation between Positron Emission Tomography with ¹¹C-5-Hydroxytryptophane (5-HTP) and Surgical Findings in Abdominal Neuroendocrine Tumours

Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec®)

Kindmark, Henrik; Janson, Eva Tiensuu; Gustavsson, Bengt; Eriksson, Camilla et al.

Part of Acta Oncologica, p. 100-101, 2010

• DOI for Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec®)

Mitotane Effects in a H295R Xenograft Model of Adjuvant Treatment of Adrenocortical Cancer

Lindhe, Örjan; Skogseid, Britt

Part of Hormone and Metabolic Research, p. 725-730, 2010

• DOI for Mitotane Effects in a H295R Xenograft Model of Adjuvant Treatment of Adrenocortical Cancer

Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel

Berruti, Alfredo; Fassnacht, Martin; Baudin, Eric; Hammer, Gary et al.

Part of Journal of Clinical Oncology, 2010

• DOI for Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel

Spectral Karyotypic and Comparative Genomic Analysis of the Endocrine Pancreatic Tumor Cell Line BON-1

Lopez, Juan R.; Claessen, Sandra M. H.; Macville, Merryn V. E.; Albrechts, Jozefa C. M. et al.

Part of Neuroendocrinology, p. 131-141, 2010

• DOI for Spectral Karyotypic and Comparative Genomic Analysis of the Endocrine Pancreatic Tumor Cell Line BON-1

Identification of Achaete-scute complex-like 1 (ASCL1) target genes and evaluation of DKK1 and TPH1 expression in pancreatic endocrine tumours

Johansson, Térèse A.; Westin, Gunnar; Skogseid, Britt

Part of BMC Cancer, p. 321, 2009

• DOI for Identification of Achaete-scute complex-like 1 (ASCL1) target genes and evaluation of DKK1 and TPH1 expression in pancreatic endocrine tumours

Identification of Achaete-scute complex-like 1 (ASCL1) target genes and evaluation of DKK1 and TPH1 expression in pancreatic endocrine tumours.

Johansson, Terese; Westin, Gunnar; Skogseid, Britt

Part of BMC Cancer, 2009

Neurogenin 3 and neurogenic differentiation 1 are retained in the cytoplasm of multiple endocrine neoplasia type 1 islet and pancreatic endocrine tumor cells

Lejonklou, Margareta Halin; Edfeldt, Katarina; Johansson, Térèse A.; Stålberg, Peter et al.

Part of Pancreas, p. 259-266, 2009

• DOI for Neurogenin 3 and neurogenic differentiation 1 are retained in the cytoplasm of multiple endocrine neoplasia type 1 islet and pancreatic endocrine tumor cells

Differentially regulated genes in MEN1-transfected BON cells using RT-differential display and oligonucleotide microarrays

Lopez-Egido, Juan R.; Wang, Yi; Grönberg, Malin; Grimfjärd, Per et al.

Part of Anticancer Research, p. 1859-1866, 2009

Elevated Plasma Chromogranin A is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumours

Welin, Staffan; Stridsberg, Mats; Cunningham, Janet; Granberg, Dan et al.

Part of Neuroendocrinology, p. 302-307, 2009

• DOI for Elevated Plasma Chromogranin A is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumours

The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors

Tacon, Lyndal J.; Soon, Patsy S.; Gill, Anthony J.; Chou, Angela S. et al.

Part of Journal of Clinical Endocrinology and Metabolism, p. 4591-4599, 2009

• DOI for The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors

Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors

Eriksson, John; Stålberg, Peter; Nilsson, Anders; Krause, Johan et al.

Part of World Journal of Surgery, p. 930-938, 2008

• DOI for Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors

Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution

Ekeblad, Sara; Skogseid, Britt; Dunder, Kristina; Oberg, Kjell et al.

Part of Clinical Cancer Research, p. 7798-7803, 2008

• DOI for Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution

Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007

Lim, Eric; Goldstraw, Peter; Nicholson, Andrew G.; Travis, William D. et al.

Part of Journal of Thoracic Oncology, p. 1194-1201, 2008

• DOI for Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007

Lack of Nuclear Expression of Hairy and Enhancer of Split-1 (HES1) in Pancreatic Endocrine Tumors

Johansson, T; Lejonklou, Margareta Halin; Ekeblad, Sara; Stålberg, Peter et al.

Part of Hormone and Metabolic Research, p. 354-359, 2008

• DOI for Lack of Nuclear Expression of Hairy and Enhancer of Split-1 (HES1) in Pancreatic Endocrine Tumors

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors

Ekeblad, Sara; Sundin, Anders; Janson, Eva Tiensuu; Welin, Staffan et al.

Part of Clinical Cancer Research, p. 2986-2991, 2007

• DOI for Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors

Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years

Kindmark, Henrik; Sundin, Anders; Granberg, Dan; Dunder, Kristina et al.

Part of Medical Oncology, p. 330-337, 2007

• DOI for Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years

Liver embolization with trisacryl gelatin microspheres (embosphere) in patients with neuroendocrine tumors

Granberg, Dan; Eriksson, Lars-Gunnar; Welin, Staffan; Kindmark, Henrik et al.

Part of Acta Radiologica, p. 180-185, 2007

• DOI for Liver embolization with trisacryl gelatin microspheres (embosphere) in patients with neuroendocrine tumors

DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients

Jonkers, Y. M. H.; Claessen, S. M. H.; Perren, A.; Schmitt, A. M. et al.

Part of Endocrine-Related Cancer, p. 769-779, 2007

• DOI for DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients

Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases

Tham, Emma; Grandell, Ulla; Lindgren, Eva; Toss, Göran et al.

Part of Journal of Clinical Endocrinology and Metabolism, p. 3389-3395, 2007

• DOI for Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases

Co-expression of ghrelin and its receptor in pancreatic endocrine tumours

Ekeblad, Sara; Lejonklou, Margareta Halin; Grimfjärd, Per; Johansson, Térèse et al.

Part of Clinical Endocrinology, p. 115-122, 2007

• DOI for Co-expression of ghrelin and its receptor in pancreatic endocrine tumours

Gastrointestinal stromal tumors express the orexigen ghrelin

Ekeblad, Sara; Nilsson, Bengt; Lejonklou, Margareta Halin; Johansson, Térèse et al.

Part of Endocrine-Related Cancer, p. 963-970, 2006

• DOI for Gastrointestinal stromal tumors express the orexigen ghrelin

Lungcarcinoider: inte så benigna som man trott

Granberg, Dan; Eriksson, Barbro; Janson, Eva Tiensuu; Öberg, Kjell et al.

Part of Läkartidningen, p. 2382-2384, 2006

Gastrin-releasing-peptide in neuroendorine tumours

Granberg, Dan; Skogseid, Britt; Welin, Staffan; Örlefors, Håkan et al.

Part of Acta Oncologica, p. 23-27, 2006

• DOI for Gastrin-releasing-peptide in neuroendorine tumours

Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 status

Jonkers, Y. M. H.; Claessen, S. M. H.; Veltman, J. A.; Geurts van Kessel, A. et al.

Part of Cytogenetic and Genome Research, p. 289-297, 2006

• DOI for Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 status

Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays

Stålberg, Peter; Santesson, Mårten; Ekeblad, Sara; Lejonklou, Margareta Halin et al.

Part of Surgery, p. 921-931, 2006

• DOI for Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays

Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1.

Hellman, P; Hennings, J; Åkerström, G; Skogseid, B

Part of BJS, p. 1508-12, 2005

Whole-Body 11C-5-Hydroxytryptophan Positron Emission Tomography as a Universal Imaging Technique for Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and Computed Tomography

Örlefors, Håkan; Sundin, Anders; Garske, Ulrike; Juhlin, Claes et al.

Part of Journal of Clinical Endocrinology and Metabolism, p. 3392-3400, 2005

• DOI for Whole-Body 11C-5-Hydroxytryptophan Positron Emission Tomography as a Universal Imaging Technique for Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and Computed Tomography

Radiofrequency ablation of neuroendocrine liver metastases

Elvin, A; Skogseid, B; Hellman, Per

Part of Abdom Imaging, 2005

High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours

Welin, Staffan; Janson, Eva Tiensuu; Sundin, Anders; Stridsberg, Mats et al.

Part of European Journal of Endocrinology, p. 107-112, 2004

• DOI for High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours

Transfection of the multiple endocrine neoplastia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of junD, delta-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen and QM/Jif-1

Stålberg, Peter; Grimfjärd, Per; Santesson, Mårten; Zhou, Yinghua et al.

Part of The journal of clinical endocrinology & metabolism, p. 2326-2337, 2004

Octreoscan in patients with bronchial carcinoid tumours.

Granberg, Dan; Sundin, Anders; Tiensuu Janson, Eva; Oberg, Kjell et al.

Part of Clin Endocrinol (Oxf), p. 793-9, 2003

In Situ RNA-RNA Hybridization of Phospholipase C β3 Shows Lack of Expression in Neuroendocrine Tumours

Stålberg, Peter; Granberg, Dan; Carling, Tobias; Wilander, Erik et al.

Part of Anticancer Research, p. 2227-2232, 2003

Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases

Hellman, Per; Lundström, Tobias; Öhrvall, Ulf; Eriksson, Barbro et al.

Part of World Journal of Surgery, p. 991-997, 2002

• DOI for Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases

Cytochrome P450-catalysed binding of 3-methylsulfonyl-DDE and o,p´-DDD in human adrenal zona fasciculata/reticularis

Lindhe, Örjan; Skogseid, Britt; Brandt, Ingvar

Part of Journal of Clinical Endocrinology & Metabolism, p. 1319-1326, 2002

Cytochrome P450-catalyzed binding of 3-methylsulfonyl-DDE and o,p'-DDD in human adrenal zona fasciculata/reticularis.

Lindhe, Örjan; Skogseid, Britt; Brandt, Ingvar

Part of J Clin Endocrinol Metab, p. 1319-26, 2002

Radiofrequency tissue ablation using colled tip for liver metastases of endocrine tumors

Hellman, Per; Ladjevardi, Sam; Skogseid, Britt; Åkerström, Göran et al.

Part of World J Surg, p. 1052, 2002

Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN1

Åkerström, Göran; Hessman, Ola; Skogseid, Britt

Part of Langenbeck's Archives of Surgery, p. 558-569, 2002

Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.

Hellman, P; Lundstrom, T; Ohrvall, U; Eriksson, B et al.

Part of World J Surg, p. 991, 2002

Multiple allelic deletions and intratumoral genetic heterogeneity in MEN1 pancreatic tumors

Hessman, Ola; Skogseid, Britt; Westin, Gunnar; Åkerström, Göran

Part of Journal of Clinical Endocrinology and Metabolism, p. 1355-1361, 2001

• DOI for Multiple allelic deletions and intratumoral genetic heterogeneity in MEN1 pancreatic tumors

Experience in treatment of metastatic pulmonary carcinoid tumors

Granberg, Dan; Eriksson, Barbro; Wilander, Erik; Grimfjärd, Per et al.

Part of Annals of Oncology, p. 1383-1391, 2001

Nonsurgical treatment of advanced malignant neuroendocrine pancreatictumors and midgut carcinoids.

Skogseid, B

Part of World J Surg, p. 700, 2001

Differentially expressed cDNAs in PLCbeta3-induced tumor suppression in a human endocrine pancreatic tumor cell line: activation of the human mismatch repair protein 3 gene.

Stålberg, P; Lopez-Egido, J R; Wang, S; Gobl, A et al.

Part of Biochem Biophys Res Commun, p. 227-31, 2001

Carcinoid syndrome symposium on treatment modalities for gastrointestinalcarcinoid tumours: symposium summary.

Pasieka, JL; McKinnon, JG; Kinnear, S; Yelle, CA et al.

Part of Can J Surg, p. 25, 2001

Streptozocin and o,p'DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use

Khan, Tanweera Shaheena; Imam, Hassan; Juhlin, Claes; Skogseid, Britt et al.

Part of Annals of Oncology, p. 1281-1287, 2000

Subcellular distribution of phospholipase C isoforms in rodent pancreas and gastric mucosa

Wang, Shu; Lukinius, Agneta; Zhou, Yinghua; Stålberg, Peter et al.

Part of Endocrinology, p. 2589-2593, 2000

• DOI for Subcellular distribution of phospholipase C isoforms in rodent pancreas and gastric mucosa

Prognostic markers in patients with typical bronchial carcinoid tumors

Granberg, Dan; Wilander, Erik; Öberg, Kjell; Skogseid, Britt

Part of Journal of Clinical Endocrinology and Metabolism, p. 3425-3430, 2000

• DOI for Prognostic markers in patients with typical bronchial carcinoid tumors

Surgical strategy for large or malignant endocrine pancreatic tumors

Hellman, Per; Andersson, Maria; Rastad, Jonas; Juhlin, Claes et al.

Part of World Journal of Surgery, p. 1353-1360, 2000

• DOI for Surgical strategy for large or malignant endocrine pancreatic tumors

Subcellular distribution of phospholipase C isoforms in rodent pancreas and gastric mucosa.

Wang, S; Lukinius, A; Zhou, Y; Stålberg, P et al.

Part of Endocrinology, p. 2589-93, 2000

Positron emission tomography in neuroendocrine tumours

Eriksson, Barbro; Örlefors, Håkan; Sundin, Anders; Skogseid, Britt et al.

Part of The Italian Journal of Gastroenterology and Hepatology, 1999

Decreased survival in patients with CD44-negative typical bronchial carcinoid tumors

Granberg, Dan; Wilander, Erik; Öberg, Kjell; Skogseid, Britt

Part of International Journal of Cancer, p. 484-488, 1999

• DOI for Decreased survival in patients with CD44-negative typical bronchial carcinoid tumors

Suppression of the neoplastic phenotype by transfection of phospholipase C3 to neuroendocrine tumor cells

Stålberg, Peter; Wang, Shu; Larsson, Catharina; Weber, Günther et al.

Part of FEBS Letters, p. 210-216, 1999

• DOI for Suppression of the neoplastic phenotype by transfection of phospholipase C3 to neuroendocrine tumor cells

Multiple endocrine neoplasia type 1: clinical and genetic features

Skogseid, Britt; Doherty, G M

Part of The Italian Journal of Gastroenterology and Hepatology, 1999

Positron emission tomography in neuroendocrine tumors

Eriksson, Barbro; Örlefors, Håkan; Sundin, Anders; Skogseid, Britt et al.

Part of The Italian Journal of Gastroenterology and Hepatology, p. 167-171, 1999

Treatment with high dose [(111)In-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors: evaluation of therapeutic and toxic effects

Tiensuu Janson, Eva; Eriksson, Barbro; Öberg, Kjell; Skogseid, Britt et al.

Part of Acta Oncologica, p. 373-377, 1999

• DOI for Treatment with high dose [(111)In-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors: evaluation of therapeutic and toxic effects

Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism

Gobl, Anders E; Berg, Mikael; Lopez-Egido, Juan R; Öberg, Kjell et al.

Part of Biochimica et Biophysica Acta, p. 51-56, 1999

• DOI for Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism

Plasma Chromogranin A In Patients with Multiple Endocrine Neoplasia Type 1

Granberg, Dan; Stridsberg, Mats; Seensalu, Rein; Eriksson, Barbro et al.

Part of Journal of Clinical Endocrinology and Metabolism, p. 2712-2717, 1999

Targeted disruption of the mouse phospholipase C β3 gene results in early embryonic lethality

Wang, Shu; Gebre-Medhin, Samuel; Betsholtz, Christer; Stålberg, Peter et al.

Part of FEBS Letters, p. 261-265, 1998

• DOI for Targeted disruption of the mouse phospholipase C β3 gene results in early embryonic lethality

Molecular cloning and characterization of a cDNA encoding mouse phospholipase C-β3

Wang, Shu; Zhou, Yinghua; Lukinius, Agneta; Öberg, Kjell et al.

Part of Biochimica et Biophysica Acta, p. 173-178, 1998

• DOI for Molecular cloning and characterization of a cDNA encoding mouse phospholipase C-β3

Mutation of the Multiple Endocrine Neoplasia Type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas

Hessman, Ola; Lindberg, Daniel; Skogseid, Britt; Carling, Tobias et al.

Part of Cancer Research, p. 377-379, 1998

Limited tumor involvement found at multiple endocrine neoplasia type I pancreatic exploration: can it be predicted by preoperative tumor localization?

Skogseid, Britt; Öberg, Kjell; Åkerström, Göran; Eriksson, Barbro et al.

Part of World Journal of Surgery, p. 673-677; discussion 667-668, 1998

• DOI for Limited tumor involvement found at multiple endocrine neoplasia type I pancreatic exploration: can it be predicted by preoperative tumor localization?

Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommendation by a consensus workshop

Wiedenmann, Bertram; Jensen, RT; Mignon, Michel; Modlin, I et al.

Part of World Journal of Surgery, p. 309-318, 1998

• DOI for Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommendation by a consensus workshop

Thymic carcinoids in multiple endocrine neoplasia type 1

Teh, Bin T; Zedenius, J; Kytola, S; Skogseid, Britt et al.

Part of Annals of Surgery, p. 99-105, 1998

Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors

Eriksson, B. K.; Larsson, E. G.; Skogseid, Britt M.; Löfberg, Anne-Marie et al.

Part of Cancer, p. 2293-2301, 1998

• DOI for Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors

Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1

Hellman, Per; Skogseid, Britt; Öberg, Kjell; Juhlin, Claes et al.

Part of Surgery, p. 993-999, 1998

Parathyroid MEN 1 gene mutations in relation to clinical characteristics of non-familial primary hyperparathyroidism

Carling, Tobias; Correa, P; Hessman, Ola; Hedberg, J et al.

Part of Journal of Clinical Endocrinology and Metabolism, p. 2960-2963, 1998

• DOI for Parathyroid MEN 1 gene mutations in relation to clinical characteristics of non-familial primary hyperparathyroidism

Targeted disruption of the mouse PLC b3 gene results in defective preimplantation and tumor predisposition

Wang, She; Gebre-Medhin, S; Betsholtz, C; Stålberg, Peter et al.

Part of FEBS Letters, p. 261-265, 1998

• DOI for Targeted disruption of the mouse PLC b3 gene results in defective preimplantation and tumor predisposition

Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids

Granberg, Dan; Wilander, Erik; Stridsberg, Mats; Granerus, Göran et al.

Part of Gut, p. 223-228, 1998

Postoperative recurrence and hypoparathyroidism in hyperparathyroidism of multiple endocrine neoplasia type 1

Hellman, Per; Skogseid, Britt; Öberg, Kjell; Juhlin, Claes et al.

Part of Surgery, p. 993-999, 1998

Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I

Skogseid, Britt; Öberg, Kjell; Eriksson, Barbro; Juhlin, Claes et al.

Part of World Journal of Surgery, p. 872-877, 1996

• DOI for Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I

Definition of the minimal MEN 1 candidate area based on a 5-Mb integrated map proximal to 11q13: The european consortium on men1

Courseaux, A; Grosgeorge, J; Gaudray, P; Pannett, AA et al.

Part of Genomics, p. 345-353, 1996

• DOI for Definition of the minimal MEN 1 candidate area based on a 5-Mb integrated map proximal to 11q13: The european consortium on men1

Efficiency of percutaneous core biopsy in pancreatic tumor diagnosis

Karlsson, Britt-Marie; Andersson Forsman, Catarina; Wilander, Erik; Skogseid, Britt et al.

Part of Surgery, p. 75-79, 1996

• DOI for Efficiency of percutaneous core biopsy in pancreatic tumor diagnosis

Operative tumour yield obviates preoperative pancreatic tumour localization in multiple endocrine neoplasia type 1

Skogseid, Britt; Grama, D; Rastad, J; Eriksson, Barbro et al.

Part of Journal of Internal Medicine, p. 281-288, 1995

Adrenal lesions in multiple endocrine neoplasia type 1

Skogseid, Britt; Rastad, Jonas; Gobl, Anders; Larsson, Catharina et al.

Part of Surgery, p. 1077-1082, 1995

• DOI for Adrenal lesions in multiple endocrine neoplasia type 1

Candidate genes for multiple endocrine neoplasia type 1

Lagercrantz, J; Larsson, C; Grimmond, S; Skogseid, Britt et al.

Part of Journal of Internal Medicine, p. 245-248, 1995

Assignment of the mouse homologue of a MEN 1 candidate gene, phospholipase C-beta3 (Plcb3), to chromosome region 19B by FISH

Gobl, Anders; Chowdhary, BP; Shu, Wang; Eriksson, L et al.

Part of Cytogenetics and Cell Genetics, p. 257-259, 1995

Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours

Stridsberg, Mats; Eriksson, Barbro; Lundqvist, Gudmar; Skogseid, Britt et al.

Part of Regulatory Peptides, p. 119-131, 1995

• DOI for Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours

Experience with multiple endocrine neoplasia type 1 screening

Skogseid, Britt; Öberg, Kjell

Part of Journal of Internal Medicine, p. 255-261, 1995

Operative tumor yield obviates preoperative pancreatic localization in multiple endocrine neoplasia type 1

Skogseid, Britt; Grama, D; Rastad, Jonas; Eriksson, Barbro et al.

Part of Journal of Internal Medicine, p. 281-288, 1995

Immunohistochemical expression of insulin-like growth factor 1 and its receptor in normal and neoplastic human adrenal cortex

Backlin, Carin; Rastad, Jonas; Skogseid, Britt; Hellman, Per et al.

Part of Anticancer Research, p. 2453-2459, 1995

Hyperparathyroidism of multiple endocrine neoplasia type 1: candidate gene and parathyroid calcium sensing protein expression

Carling, Tobias; Rastad, Jonas; Ridefelt, Peter; Gobl, Anders et al.

Part of Surgery, p. 924-931, 1995

• DOI for Hyperparathyroidism of multiple endocrine neoplasia type 1: candidate gene and parathyroid calcium sensing protein expression

The phospholipase C b 3 gene located in the MEN 1 region shows loss of expression in endocrine tumors

Weber, G; Friedman, E; Grimmond, S; Hayward, N K et al.

Part of Human Molecular Genetics, p. 1775-1781, 1994

• DOI for The phospholipase C b 3 gene located in the MEN 1 region shows loss of expression in endocrine tumors

Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors

Chaudhry, Arvind; Gobl, Anders; Eriksson, Barbro; Skogseid, Britt et al.

Part of Cancer Research, p. 981-986, 1994

Multiple endocrine neoplasia type 1. Clinical features and screening.

Skogseid, B; Rastad, J; Oberg, K

Part of Endocrinol Metab Clin North Am, p. 1-18, 1994

Screening for multiple endocrine neoplasia type 1 syndrome

Skogseid, Britt; Eriksson, Barbro; Åkerström, Göran; Rastad, J et al.

Part of Diagnostic oncology, p. 91-95, 1993

Pancreatic tumors in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment

Grama, D; Skogseid, Britt; Wilander, Erik; Eriksson, Barbro et al.

Part of World Journal of Surgery, p. 611-618, 1992

• DOI for Pancreatic tumors in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment

Multiple endocrine neoplasia type 1: a ten year prospective screening study in four kindreds

Skogseid, Britt; Eriksson, Barbro; Lundqvist, Gudmar; Lörelius, Lars Erik et al.

Part of Journal of Clinical Endocrinology and Metabolism, p. 281-287, 1991

• DOI for Multiple endocrine neoplasia type 1: a ten year prospective screening study in four kindreds

Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors

Eriksson, Barbro; Skogseid, Britt; Lundqvist, Gudmar; Wide, Leif et al.

Part of Cancer, p. 1883-1890, 1990

• DOI for Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors

Neuroendocrine pancreatic tumours: clinical presentation, biochemical and histopathological findings in 84 patients

Eriksson, Barbro; Arnberg, H; Lindgren, PG; Lörelius, LE et al.

Part of Journal of Internal Medicine, p. 103-113, 1990

• DOI for Neuroendocrine pancreatic tumours: clinical presentation, biochemical and histopathological findings in 84 patients

[New medical therapy of neuroendocrine gastrointestinal tumors]

Eriksson, B; Janson, E T; Skogseid, B; Oberg, K

Part of Lakartidningen, p. 2668-72, 1990

Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis

Crona, Joakim; Lamarca, Angela; Ghosal, Suman; Welin, Staffan et al.

Part of Endocrine-Related Cancer, p. 539-550, 2019

• DOI for Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis

Advances in adrenal tumors 2018

Crona, Joakim; Beuschlein, F.; Pacak, K.; Skogseid, Britt

Part of Endocrine-Related Cancer, 2018

• DOI for Advances in adrenal tumors 2018
• Download full text (pdf) of Advances in adrenal tumors 2018

Genetics of neuroendocrine tumors

Crona, Joakim; Skogseid, Britt

Part of European Journal of Endocrinology, 2016

• DOI for Genetics of neuroendocrine tumors

The ultimate biochemical diagnosis of endocrine pancreatic tumours in MEN-1.

Oberg, K; Skogseid, B

Part of J Intern Med, p. 471-6, 1998

Surgical Endocrinology

Doherty, Gerhard; Skogseid, Britt

Lippincott Williams & Wilkins, 2000

Multiple Endocrine Neoplasia type 2

Åkerström, Göran; Stålberg, Peter; Skogseid, Britt

Part of Textbook of Complex General Surgical Oncology, McGraw-Hill, 2018

Developments in the Life Sciences

Skogeid, Britt

Part of Scholars in Action, p. 123-138, Acta Universitatis Upsaliensis, 2012

• Download full text (pdf) of Developments in the Life Sciences

Pancreatic tumours as part of the MEN-1 syndrome.

Åkerström, Göran; Hessman, Ola; Hellman, Per; Skogseid, Britt

Part of Best Practice & Research Clinical Endocrinology & Metabolism, Elsevier, 2005

• DOI for Pancreatic tumours as part of the MEN-1 syndrome.

Endokrina tumörer i mag-tarmkanalen och pancreas

Ahrén, B; Skogseid, Britt

Part of Endokrinology, Liber, 2005

Surgical Endocrinology: Lung and thymic neuroendocrine tumors

Granberg, Dan; Skogseid, Britt

Part of Surgical endocrinology, p. 413-430, Lippincot, Williams and Wilkins Publischers, 2001

Pancreatic endocrine tumors in multiple endocrine neoplasia type 1

Skogseid, Britt; Rastad, J; Åkerström, Göran

Part of Surgical Endocrinolgy, p. 511-524, Lippincot, Williams and Wilkins Publischers, 2001

Surgical Endocrinology: Pancreatic endocrine tumors in multiple endocrine neoplasia type 1

Skogseid, Britt

Part of Surgical Endocrinology, Lippincot, Williams and Wilkins Publischers, 2001

Lung and thymic carcinoids

Granberg, Dan; Skogseid, Britt

Part of Surgical endocrinology, Lippincott Williams & Wilkins, 2001

Pancreatic endocrine tumors in multipible endocrine neoplasia type 1

Skogseid, Britt; Rastad, Jonas; Åkerström, Göran

Part of Surgical Endocrinology, p. 511-524, Lippincott Williams & Wilkins, 2001

Endocrine pancreatic tumors without hormonal symptoms

Rastad, J; Skogseid, Britt

Part of Endocrinologia, McGraw-Hill Interamericana, 2000

Clinical challenges in hereditary pancreatic endocrine tumors: Multiple endocrine neoplasia type 1

Skogseid, Britt; Doherty, G M

Part of Recent Advances in the pathophysiology and management of inflammatory bowel diseases and digestive endocrine tumors, p. 241-247, John Libbey Publishing, 1999

Multiple endocrine neoplasia type 1: Clinical genetics and diagnosis

Skogseid, Britt

Part of Endocrine Neoplasms, p. 383-406, Kluwer Academic Publishers, 1997

Diagnosis measures in MEN 1 families

Rastad, Jonas; Skogseid, Britt

Part of  Endocrinologia, McGraw-Hill Interamericana, 1996

Genetics of multiple endocrine neoplasia type 1

Skogseid, Britt; Öberg, Kjell

Part of Endocrine tumors of the pancreas, S. Karger, 1995

Familial hyperparthyroidism

Åkerström, Göran; Skogseid, Britt; Rastad, J

Part of Current controversy in parathyroid operation adn reoperation, p. 115-130, 1994

The relationship between traumatic stress, experiential avoidance, and depression in parents of children recently diagnosed with cancer

Cernvall, Martin; Skogseid, Ellen; Ljungman, Lisa; Ljungman, Gustaf et al.

Part of 12th international Congress of Behavioral Medicine, 29 August - 1 September 2012, Budapest Hilton Hungary, p. 138-138, 2012

Quantitative Protein Profiling of Adrenal Glands in a Men1 Mouse Model

Chu, Xia; Monazzan, Azita; Razmara, Masoud; Stålberg, Peter et al.

MicroRNA Expression Profiling in adrenals of Multiple Endocrine Neoplasia type 1 Mice

Monazzan, Azita; Chu, Xia; Stålberg, Peter; Skogseid, Britt

Survival and Clinical Characteristics in 284 Patients with Malignant Midgut Carcinoid Tumors

Welin, Staffan; Janson, Eva T.; Granberg, Dan; Kindmark, Henrik et al.

Notch signaling factors in the transforming Men1 mouse pancreas

Halin Lejonklou, Margareta; Johansson, Térèse; Ekeblad, Sara; Skogseid, Britt